Evidence map›Paper›PMID 20945090›Full record

Trial reportBreast cancer research and treatment2011

The benefits of discussing adjuvant therapies one at a time instead of all at once.

Brian J Zikmund-Fisher, Andrea M Angott, Peter A Ubel

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Breast cancer research and treatment, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
11.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Communicating treatment risks and benefits to cancer patients: a systematic review of communication methods.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2020
    Pooled it
  2. Trial
  3. Presenting Numeric Information with Percentages and Descriptive Risk Labels: A Randomized Trial.Medical decision making : an international journal of the Society for Medical Decision Making · 2015
    Trial
  4. Article
  5. Article
  6. Cocreation with Dutch patients of decision-relevant information to support shared decision-making about adjuvant treatment in breast cancer care.Health expectations : an international journal of public participation in health care and health policy · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Graphics help patients distinguish between urgent and non-urgent deviations in laboratory test results.Journal of the American Medical Informatics Association : JAMIA · 2017
    Article
  11. Subjective Numeracy and the Influence of Order and Amount of Audible Information on Perceived Medication Value.Medical decision making : an international journal of the Society for Medical Decision Making · 2017
    Article
  12. Article
  13. Observational
  14. Article
  15. Blocks, ovals, or people? Icon type affects risk perceptions and recall of pictographs.Medical decision making : an international journal of the Society for Medical Decision Making · 2014
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Brian J Zikmund-FisherDepartment of Health Behavior and Health Education, University of Michigan, Ann Arbor, MI 48109-2029, USA. bzikmund@umich.edu
Andrea M Angott
Peter A Ubel
Duke University · USUniversity of Michigan–Ann Arbor · US

Funding

IDENTIFY &REDUCE COGNITIVE BIASES OF DECISION AIDSR01CA087595 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI UBEL, PETER A · 2002 to 2011
$4.2M
NCI NIH HHS R01 CA087595NCI NIH HHS R01 CA87595
6 · The paper itself

Abstract

Breast cancer patients must often decide between multiple adjuvant therapy options to prevent cancer recurrence. Standard practice, as implemented in current decision support tools, is to present information about all options simultaneously, but psychology research suggests that sequential decision processes might improve decision making. We tested whether asking women to consider hormonal therapy and chemotherapy separately would improve women's risk knowledge and/or affect treatment intentions. We conducted an Internet-administered experimental survey of a demographically diverse sample of 1,781 women ages 40-74. Participants were randomized to experience a standard, comprehensive decision process versus sequential (one at a time) decisions regarding adjuvant therapy options for a hypothetical breast cancer patient with an estrogen receptor-positive (ER+) tumor. We assessed comprehension of key statistics, perceptions of treatment effectiveness, and perceived interest in adjuvant chemotherapy, as well as participants' numeracy levels. When participants made sequential decisions, they demonstrated greater comprehension of decision-relevant risk statistics, as compared to when they made decisions all at once (all P's < 0.001). Among higher-numeracy participants, those making sequential decisions were less interested in chemotherapy (P < 0.001). Lower-numeracy participants who considered all options simultaneously were insensitive to the degree of risk reduction, but those who made sequential decisions were sensitive (P = 0.03). In conclusion, presenting adjuvant therapy options sequentially improves women's comprehension of incremental treatment benefit and increases less numerate women's sensitivity to the magnitude of the achievable risk reduction over standard, all at once approaches. Sequential approaches to adjuvant therapy decisions may reduce use of chemotherapy among those at low risk for recurrence.

Indexed as

AdultAgedAntineoplastic Agents, HormonalAntineoplastic Combined Chemotherapy ProtocolsBreast NeoplasmsChemotherapy, AdjuvantFemaleHumansMiddle AgedPatient Education as TopicRisk FactorsTreatment OutcomeAntineoplastic Agents, Hormonal

Identifiers

PMID20945090
PMCPMC3574293
OpenAlexW2057437077

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.